About: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide Goto Sponge Distinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description	Having demonstrated short-term weight loss with liraglutide in this group of obese adults, we now evaluate safety/tolerability (primary outcome) and long-term efficacy for sustaining weight loss (secondary outcome) over 2 years. Having demonstrated short-term weight loss with liraglutide in this group of obese adults, we now evaluate safety/tolerability (primary outcome) and long-term efficacy for sustaining weight loss (secondary outcome) over 2 years. (en)
Title	Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide (en)
skos:prefLabel	Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide (en)
skos:notation	RIV/00023761:_____/12:#0000216!RIV13-MZ0-00023761
http://linked.open...avai/predkladatel	Endokrinologický ústav
http://linked.open...avai/riv/aktivita	V
http://linked.open...avai/riv/aktivity	V
http://linked.open...iv/cisloPeriodika	6
http://linked.open...vai/riv/dodaniDat	2013
http://linked.open...aciTvurceVysledku	Kunešová, Marie
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Endokrinologický ústav
http://linked.open...dnocenehoVysledku	166653
http://linked.open...ai/riv/idVysledku	RIV/00023761:_____/12:#0000216
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	liraglutide (en)
http://linked.open.../riv/klicoveSlovo	liraglutide
http://linked.open...odStatuVydavatele	GB - Spojené království Velké Británie a Severního Irska
http://linked.open...ontrolniKodProRIV	[5D1B05231485]
http://linked.open...i/riv/nazevZdroje	International journal of obesity
http://linked.open...in/vavai/riv/obor	FB
http://linked.open...ichTvurcuVysledku	1 (xsd:int)
http://linked.open...cetTvurcuVysledku	12 (xsd:int)
http://linked.open...UplatneniVysledku	2012
http://linked.open...v/svazekPeriodika	36
http://linked.open...iv/tvurceVysledku	Kunešová, Marie
http://linked.open...ain/vavai/riv/wos	000305282400012
issn	0307-0565
number of pages	12 (xsd:int)
is http://linked.open...avai/riv/vysledek of	Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 85 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software